A new kind of implant may offer people suffering from sleep apnea an alternative to wearing an air mask while they snooze, researchers report. With the implant, a pacemaker delivers electrical impulses to a nerve that controls the tongue ...
The U.S. Food and Drug Administration approved Mekinist, or trametinib, in combination with Tafinlar, or dabrafenib, to treat patients with advanced melanoma. Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products ...
Tags: Skin Cancer, Health, Medicine
Matt G. Kushner, Ph.D., professor of Psychiatry, University of Minnesota (Minneapolis) has earned the latest Dan Anderson Research Award for his study examining the effectiveness of a hybrid cognitive behavioral therapy in the treatment of ...
Tags: Hybrid CBT, Hazelden's Dan Anderson Research Award, Hybrid CBT Study
BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical-grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues, today ...
Three hundred children are being recruited for a clinical trial to establish whether or not specialist silk clothing really does help in the treatment of eczema. The £1m CLOTHES trial — Clothing for the relief of Eczema ...
Tags: clinical trial, silk clothing, eczema, Kim Thomas
RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("the Company" or "RegeneRx") announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development (OOPD) for its drug candidate, Thymosin beta 4 ...
Tags: RegeneRx Biopharmaceuticals, Orphan Drug designation, Thymosin beta 4
Cerenis Therapeutics, the biopharmaceutical company, today announced that its Phase IIb CHI-SQUARE (Can HDL Infusions Significantly Quicken Atherosclerosis REgression) study did not reach its primary endpoint in post-Acute Coronary Syndrome ...
Tags: Cerenis Therapeutics, Phase IIb CHI-SQUARE, post-Acute Coronary Syndrome
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network ...
Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) ...
Tags: Can-Fite BioPharma, OphthaliX, placebo-controlled phase III study
A new analysis has found that both real and sham acupuncture treatments may help alleviate side effects of drugs commonly used to treat breast cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, ...
Tags: acupuncture treatments, breast cancer, alleviate side effects
Researchers at Penn Medicine report in the December 25 issue of JAMA that a modified form of prolonged exposure therapy - in which patients revisit and recount aloud their trauma-related thoughts, feelings and situations - shows greater ...
Tags: Penn Medicine, prolonged exposure therapy, posttraumatic stress disorder
Smokers who have a CT scan to check for lung cancer stand a nearly one-in-five chance that doctors will find and potentially treat a tumor that would not have caused illness or death, researchers report. Despite the finding, major medical ...
Tags: lung cancer, over-diagnosis
Preliminary research shows that gene therapy might one day be a powerful weapon against leukemia and other blood cancers. The experimental treatment coaxed certain blood cells into targeting and destroying cancer cells, according to ...
Tags: gene therapy, leukemia, blood cancer
Integra LifeSciences, has announced the completion of patient enrollment in a pivotal clinical trial designed to assess the safety and effectiveness of Integra dermal regeneration template in the treatment of diabetic foot ulcers. Integra ...
The first device to treat migraine pain when the headache is preceded by an often-visual disturbance called an aura has been approved by the U.S. Food and Drug Administration. The Cerena Transcranial Magnetic Stimulator (TMS) is held to ...